Itching drug trial for dialysis patients halted early
Symptom relief
Terminated
This study tested a skin-applied drug called LT5001 for severe itching in people on hemodialysis. The trial was stopped early after enrolling only 18 participants. The main goal was to check safety and how the drug behaves in the body, not to prove it works.
Phase: PHASE1, PHASE2 • Sponsor: Lumosa Therapeutics Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC